California public interest group Center for Environmental Health has threatened to sue Apple Inc. after a Greenpeace report revealed the company’s iPhone contained phthalate esters and other toxic chemicals.
California has placed a ban on toys and baby goods that are tainted with phthalate, a chemical that scientists say could lead to developmental problems.
Medtronic Inc. announced Monday that it will no longer sell an electrical lead used in its implantable defibrillators because it may be prone to fracturing and has been identified as a possible factor in five deaths, though it does not recommended removing leads that have already been implanted.
A Nevada jury dealt a blow to three breast cancer sufferers on Friday, slashing $100 million off a judgment it had awarded against drug maker Wyeth Pharmaceuticals Inc. just two days earlier.
A West Virginia jury has reportedly ordered DuPont to pay about $55.5 million for property cleanup claims at a 112-acre waste site believed to be contaminated with arsenic, cadmium and lead.
Pharmaceutical giant Pfizer Inc. has won its bid to have hundreds of plaintiffs tossed from the multidistrict litigation over its anti-inflammatory drugs Bextra and Celebrex.
Bankrupt auto parts maker Dana Corp. said on Friday that it has rejected an alternative investment offer submitted by Appaloosa Management LP.
Three plaintiffs who sued airlines for allegedly causing dangerous blood clots will become the first plaintiffs in their multi-district litigation to take their cases to trial, a federal judge ruled on Friday, while one other lost on summary judgment.
A New York state court ruled on Thursday that a long-running dispute between Foster Wheeler Corp. and a group of its insurers over who should pay the costs of asbestos lawsuits will be decided under New Jersey law rather than New York law in a victory for the energy and construction conglomerate.
A judge has dismissed a proposed class action brought against Bausch & Lomb Inc. over its contact lens solution, saying the complaint failed to reach the pleading standards established in the U.S. Supreme Court's Twombly ruling.
In litigation over what's been called the largest retail security breach ever in the United States, a federal judge on Friday threw out several of the claims brought by financial institutions against retailer TJX Companies Inc., leaving only two claims remaining.
Frontier Oil Corp. and its subsidiaries have agreed to dole out $10 million to settle five consolidated lawsuits launched by over 400 plaintiffs in Beverly Hills over emissions from oil producing facilities on their school campus.
Several leading drug manufacturers are voluntarily pulling over-the-counter infant cough and cold medicines from the shelves after two studies found that hundreds of toddlers had been injured and even killed by the products.
Hoffmann-La Roche was found liable Thursday for the pain and suffering of a man who allegedly had to have his colon removed after he developed inflammatory bowel disease from taking the acne medication Accutane.
Plaintiff attorneys in the multidistrict litigation alleging Prempro and Premarin caused patients to develop breast cancer are trying to get a judge to force Wyeth Pharmaceuticals Inc. to hand over correspondence with the U.S. Food and Drug Administration regarding label changes to the hormone replacement drugs.
In a blow to a group of Aredia and Zometa plaintiffs, the judge overseeing the product liability suit involving the bone cancer drugs has rejected calls for the establishment of a dental monitoring class in the multidistrict litigation against Novartis Pharmaceuticals Corp.
A federal judge has combined a number of product liability suits over Organon International Inc.'s contraceptive device NuvaRing for the purpose of deciding whether they should be remanded to state court.
Owners of Saturn's Vue and Ion vehicles have filed a putative class action lawsuit against General Motors Corp. alleging that the “Vti” transmission GM introduced in 2002 came with an inherent design flaw that made it prone to breaking down prematurely, rendering the vehicles “virtually worthless.”
Drug maker Wyeth Pharmaceuticals Inc. has lost a third trial over its controversial hormone replacement treatment, with a Nevada jury on Wednesday awarding $134.5 million to three women who blamed the drug for their breast cancer.
A federal judge on Thursday shot down a settlement deal that Sharper Image Corp. had proposed with plaintiffs who claimed the retailer’s $300-a-pop Ionic Breeze air purifiers did more harm than good. The deal had roused some class members' ire by proposing $19 coupons for the class and $1.9 million in spoils for attorneys.